MARKET

PRENW

PRENW

Artisan Acqu
NASDAQ
0.0160
0.0000
0.00%
Closed 09:30 06/05 EDT
OPEN
0.0160
PREV CLOSE
0.0160
HIGH
0.0160
LOW
0.0160
VOLUME
1
TURNOVER
--
52 WEEK HIGH
0.0695
52 WEEK LOW
0.0077
MARKET CAP
--
P/E (TTM)
-0.0060
1D
5D
1M
3M
1Y
5Y
1D
Prenetics names Comfrt CEO Hudson Leogrande to board as independent director
PUBT · 2d ago
PRENETICS APPOINTS HUDSON LEOGRANDE, FOUNDER AND CEO OF MULTI-BILLION-DOLLAR DTC BRAND COMFRT, TO BOARD OF DIRECTORS AS IM8 ACCELERATES TIKTOK AND META EXPANSION
Reuters · 2d ago
Weekly Report: what happened at PRE last week (0525-0529)?
Weekly Report · 5d ago
Weekly Report: what happened at PRE last week (0518-0522)?
Weekly Report · 05/25 10:25
Prenetics Taps Jay Shetty as IM8 Global Ambassador Amid Surging 2026 Growth
TipRanks · 05/20 12:30
Prenetics lifts 2026 IM8 revenue outlook to $190 million-$210 million
PUBT · 05/20 12:02
PRENETICS ANNOUNCES JAY SHETTY AS IM8 GLOBAL AMBASSADOR AND SHAREHOLDER IN MULTI-YEAR PARTNERSHIP
Reuters · 05/20 12:00
Prenetics (IM8) Earnings Call Highlights Explosive Growth
TipRanks · 05/20 08:16
More
About PRENW
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients.

Webull offers Prenetics Global Ltd stock information, including NASDAQ: PRENW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRENW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PRENW stock methods without spending real money on the virtual paper trading platform.